FDA Panel Unanimously Recommends Approval for Novartis’ CAR T-Cell Therapy CTL019 – Genetic Engineering & Biotechnology News
Medscape |
FDA Panel Unanimously Recommends Approval for Novartis' CAR T-Cell Therapy CTL019
Genetic Engineering & Biotechnology News Novartis is on track to win FDA approval later this year to market the first chimeric antigen receptor (CAR) T-cell therapy, following an advisory committee's unanimous recommendation yesterday in favor of the company's leukemia-fighting treatment … A New Dawn: First CAR T Cell Recommended for FDA Approval Novel cancer treatment wins endorsement of FDA advisers FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers |
